When testing the expression levels of γH2AX in tumor tissues of mice receiving combined use of ZCCHC4-siRNA and OXA, we found that combo-treatment markedly increased phosphorylation levels of H2AX in tumors (Supplementary Fig. S8g). This evidence concerns the gene H2AX and neoplasm.